# FDA Inspection 1066917 - Biomat USA, Inc - September 06, 2018

Source: https://www.globalkeysolutions.net/records/fda_inspections/biomat-usa-inc/7e1a2f27-76cd-4c26-80a5-96e246864f43
Source feed: FDA_Inspections

> FDA Inspection 1066917 for Biomat USA, Inc on September 06, 2018. Classification: No Action Indicated (NAI).

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1066917
- Company Name: Biomat USA, Inc
- Inspection Date: 2018-09-06
- Classification: No Action Indicated (NAI)
- Project Area: Blood and Blood Products
- Product Type: Biologics
- Office Name: Center for Biologics Evaluation and Research

## Related Documents

- [FDA Inspection 897079 - 2014-09-24](https://www.globalkeysolutions.net/records/fda_inspections/biomat-usa-inc/009fdfa8-a24a-4ed3-8b04-7d2b6f7ab714)
- [FDA Inspection 739337 - 2011-08-11](https://www.globalkeysolutions.net/records/fda_inspections/biomat-usa-inc/da366e6c-a35f-4e79-aa03-c3faa3d0091a)
- [FDA Inspection 679580 - 2010-09-09](https://www.globalkeysolutions.net/records/fda_inspections/biomat-usa-inc/135706ed-757c-487e-bc40-a7d08d4d1ee5)
- [FDA Inspection 625186 - 2009-07-17](https://www.globalkeysolutions.net/records/fda_inspections/biomat-usa-inc/9ac4c910-5cb5-40f5-bcf4-550ff6c5f43e)

Company: https://www.globalkeysolutions.net/companies/biomat-usa-inc/19cb7993-ac6f-4e51-b4ff-9e3c42b0531a

Office: https://www.globalkeysolutions.net/offices/center-for-biologics-evaluation-and-research/dd9e8ea7-6f04-4ed1-b0d7-e7e6b264570d